Form 4: NEUROONE MEDICAL TECHNOLOGIES Executive Buys Shares
Insider Transaction (Form 4)
David J. Wambeke, Chief Business Officer of NEUROONE MEDICAL TECHNOLOGIES Corp, purchased 33,333 shares of common stock on August 27, 2026 for $2.01 per share.
Summary
- Open-market purchase: acquired 33,333 Common Stock at $2.01 ($66,999) on August 27, 2026; holds 199,999 after (Direct).
- Grant/award: acquired 35,000 Option to Purchase Common Stock on August 28, 2026; holds 35,000 after (Direct).
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a bullish signal: an insider made an open-market purchase of $66,999, committing personal capital to the stock.
Insider Transactions
David J. Wambeke — Officer (Chief Business Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-27 | Open-market purchase | Common Stock | 33,333 | $2 | $67.0K | 199,999 |
| 2026-08-28 | Grant/award | Option to Purchase Common Stock | 35,000 | — | — | 35,000 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-27 | Open-market purchase (33,333 shares) |
| 2026-08-28 | Grant/award (35,000 shares) |
Keywords
insider transaction, Form 4, NMTC, NEUROONE MEDICAL TECHNOLOGIES Corp, bullish, David J. Wambeke
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.